N.H. Code Admin. R. He-P 4035.05
License Amendments
Effective Oct 25, 2022(See Revision Note at part heading for He-P 4035) #6942, eff 2-1-99; ss by #8800, INTERIM, eff 2-1-07, EXPIRED: 7-31-07 New. #8959, eff 8-7-07; ss by #10897, INTERIM, eff 7-22-15, EXPIRES: 1-18-16; ss by #11011, eff 1-15-16; ss by #13048, eff 6-2-20; ss by #13473, eff 10-25-22Former Division of Public Health Services
A licensee possessing a license in accordance with He-P 4030 shall receive a license amendment before:
- (a) Receiving, preparing, or using byproduct material for a method or type of medical use not permitted by the license issued under He-P 4035;
- (b) Permitting anyone to work as an authorized user, an authorized nuclear pharmacist, or an authorized medical physicist, under the license;
- (c) Changing a radiation safety officer;
(d) Permitting an authorized user or an individual qualified to be a radiation safety officer under He-P 4035.61 and He-P 4035.73 to:
- (1) Function as a temporary radiation safety officer; and
- (2) Perform the functions of a radiation safety officer in accordance with He-P 4035.10(d);
- (e) Permitting an authorized user or an individual qualified to be an associate radiation safety officer, or before the radiation safety officer assigns duties and tasks to an associate radiation safety officer that differ from those for which this individual is authorized on the license;
- (f) Receiving byproduct material that is in excess of the licensed amount of radionuclide, or a different form, or a different radionuclide than is authorized on the license;
- (g) Receiving a sealed source from a different manufacturer or of a different model number than authorized by its license unless the sealed source is used for manual brachytherapy, is listed in the sealed source and device registry, and is in a quantity and for an isotope authorized by the license;
- (h) Adding to or changing the areas of use or address or addresses of use identified in the application or on the license;
- (i) Changing statements, representations, and procedures which are incorporated into the license;
(j) Revising procedures required by He-P 4035.50 and He-P 4035.55, if those revisions reduce radiation safety.
Source. (See Revision Note at part heading for He-P 4035) #6942, eff 2-1-99; ss by #8800, INTERIM, eff 2-1-07, EXPIRED: 7-31-07
New. #8959, eff 8-7-07; ss by #10897, INTERIM, eff 7-22-15, EXPIRES: 1-18-16; ss by #11011, eff 1-15-16; ss by #11011, eff 1-15-16; ss by #13048, eff 6-2-20; ss by #13473, eff 10-25-22
He-P 4035.06. Notifications. A licensee shall notify the DHHS/RHS in writing within 30 days when an authorized user, an authorized nuclear pharmacist, a radiation safety officer, an associate radiation safety officer, an authorized medical physicist, or ophthalmic physicist permanently discontinues performance of duties under the license, or has a name change, has appointed a temporary radiation safety officer as provided in He-P 4035.10(d), or has appointed an associate radiation safety officer as provided in He-P 4035.10(c).
Source. (See Revision Note at part heading for He-P 4035) #6942, eff 2-1-99; ss by #8800, INTERIM, eff 2-1-07, EXPIRED: 7-31-07 New. #8959, eff 8-7-07; ss by #10897, INTERIM, eff 7-22-15, EXPIRES: 1-18-16; ss by #11011, eff 1-15-16; ss by #13048, eff 6-2-20; ss by #13473, eff 10-25-22